RBC Capital maintains CVS Health (NYSE:CVS) $91 price targetBy legume / August 18, 2023 / CVS Health, Royal Bank of Canada RBC Capital analyst Ben Hendrix reiterates CVS Health (NYSE:CVS) with a Outperform and maintains $91 price target.